174 related articles for article (PubMed ID: 21231897)
1. Pharmacoeconomic evaluation of warfarin pharmacogenomics.
You JH
Expert Opin Pharmacother; 2011 Feb; 12(3):435-41. PubMed ID: 21231897
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.
Verhoef TI; Redekop WK; Veenstra DL; Thariani R; Beltman PA; van Schie RM; de Boer A; Maitland-van der Zee AH;
Pharmacogenomics; 2013 Jun; 14(8):869-83. PubMed ID: 23746182
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
Leey JA; McCabe S; Koch JA; Miles TP
Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
[TBL] [Abstract][Full Text] [Related]
5. Cost-Utility Study of Warfarin Genotyping in the VACHS Affiliated Anticoagulation Clinic of Puerto Rico.
Martes-Martinez C; Méndez-Sepúlveda C; Millán-Molina J; French-Kim M; Marín-Centeno H; Rivera-Miranda GC; Hernández-Muñoz JJ; Duconge-Soler J
P R Health Sci J; 2017 Sep; 36(3):165-172. PubMed ID: 28915306
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand.
Chong HY; Saokaew S; Dumrongprat K; Permsuwan U; Wu DB; Sritara P; Chaiyakunapruk N
Thromb Res; 2014 Dec; 134(6):1278-84. PubMed ID: 25456732
[TBL] [Abstract][Full Text] [Related]
7. The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis.
You JH; Chan FW; Wong RS; Cheng G
Thromb Haemost; 2004 Sep; 92(3):590-7. PubMed ID: 15351856
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics and warfarin therapy.
Ndegwa S
Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
Coyle D; Coyle K; Cameron C; Lee K; Kelly S; Steiner S; Wells GA
Value Health; 2013 Jun; 16(4):498-506. PubMed ID: 23796283
[TBL] [Abstract][Full Text] [Related]
10. Genotype-guided warfarin therapy: current status.
Tavares LC; Marcatto LR; Santos PCJL
Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.
Lee S; Anglade MW; Pham D; Pisacane R; Kluger J; Coleman CI
Am J Cardiol; 2012 Sep; 110(6):845-51. PubMed ID: 22651881
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
[TBL] [Abstract][Full Text] [Related]
13. A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.
Meckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DL
Pharmacoeconomics; 2010; 28(1):61-74. PubMed ID: 20014877
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
Aujesky D; Smith KJ; Roberts MS
Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic-guided dosing for warfarin: too little too late?
Wu AH
Per Med; 2018 Mar; 15(2):71-73. PubMed ID: 29714120
[No Abstract] [Full Text] [Related]
16. Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin.
Elias DJ; Topol EJ
Eur J Hum Genet; 2008 May; 16(5):532-4. PubMed ID: 18301451
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.
Davidson T; Husberg M; Janzon M; Oldgren J; Levin LÅ
Eur Heart J; 2013 Jan; 34(3):177-83. PubMed ID: 22733833
[TBL] [Abstract][Full Text] [Related]
18. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2013 Jun; 35(3):359-68. PubMed ID: 21052837
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and the management of oral anticoagulation.
Wittkowsky AK
Curr Hematol Rep; 2004 Sep; 3(5):363-7. PubMed ID: 15341704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]